Pia Cosma, Ph.D., is head of the center’s reprogramming and regeneration group and Catalan Institution for Research and Advanced Studies (ICREA) research professor.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
The research team, led by Eri Hashino, Ph.D., professor of otolaryngology at the IU School of Medicine, reported that by using a three-dimensional cell culture method they were able to coax stem cells to develop into inner-ear sensory epithelia — containing hair cells, supporting cells and neuron
The epigenetics researchers at the Babraham Institute identified the biological process that leads to global loss of the genome’s methylation memory when cells are reprogrammed at fertilization to the so-called “ground-state” development.
According to Reviva’s scientific director, Dr. Norman Makdissi, Reviva will be the only medical facility in the Middle East equipped to collect, process, preserve and transplant stem cells from four different tissue sources in patients from Lebanon and abroad.
The Forbes article, by medical reporter Larry Husten, discusses a paper published in the International Journal of Cardiology in which Darrel Francis, of the National Heart and Lung Institute, Imperial College London, UK, and several colleagues scrutinize 48 papers from the resea
While their liver might not yet be ready to treat patients — that might be as far as a decade down the road, the co-investigators in this landmark study predict — they say their work provides proof of concept for more ambitious organ-growing experiments.
The Max Planck Society’s Senate named Dr. Stratmann to the 2014–2020 term of office at its General Meeting on June 6 in Potsdam. The 59-year-old chemist is currently serving as director of the Max-Planck-Institute for Iron Research in Düsseldorf. He will take over the position from Dr.
Researchers at New York University’s Langone Medical Center have used genetically engineered mice to document for the first time the biochemical chain of events that unfolds in the wake of a fingertip amputation.
The European Court ruled last year that no patents can be granted for any technique based on human embryonic stem cells because it involved the destruction of something “capable of commencing the process of development of a human being.” The ban also included pre-established cell lines and invent
These findings provide a platform for future development of patient-specific stem/progenitor cells and more differentiated blood products for cell-replacement therapy.